New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo® Hemodialysis System

Stock Information for Outset Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Outset Medical Inc.

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Outset Medical, Inc. (NASDAQ: OM) and Encourages Investors with Substantial Losses to Contact the Firm
Outset Medical Reports Third-Quarter Results
Outset Medical to Present at the 2025 Stifel Healthcare Conference
Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.